SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
94 hedge funds and large institutions have $53.1M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 11 closing their positions.
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
26
Reduced
31
Closed
11
Calls
$33K
Puts
$14K
Net Calls
+$19K
Net Calls Change
+$183K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$975K |
2 |
AG
2
Artal Group
Luxembourg
|
$4.17M |
3 |
3
Millennium Management
New York
|
$609K |
4 |
4
Two Sigma Investments
New York
|
$222K |
5 |
GCP
5
GSA Capital Partners
London,
United Kingdom
|
$443K |